Abivax stock sinks 32% as rare malignancy events cloud solid colitis trial data
Abivax stock sinks 32% as rare malignancy events cloud solid colitis trial data
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
TORONTO, ON / ACCESS Newswire / June 22, 2026 /Adcore Inc. (TSX:ADCO)(OTCQX:ADCOF)(FSE:ADQ) ("Adcore" or the "Company"), a global leader in AI marketing te...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Abivax stock sinks 32% as rare malignancy events cloud solid colitis trial data
SpaceX filed an amended IPO prospectus on Monday, stating that its agreement with Anthropic has an initial term of three months.
European stocks rise amid upbeat STMicro outlook, Iran talks uncertainty
Luxury brands seek to lure America's AI super-rich
The chairman of South Korea's SK Group said on Tuesday its memory chip âEUR?'unit SK Hynix aims to double wafer capacity âEUR?'over the next five years. Ch...
FTSE 100 today: Stocks edge higher as US-Iran talks support sentiment
Intel (NASDAQ:INTC) used its COMPUTEX 2026 keynote to outline a broad push across PCs, edge computing, data centers, custom silicon and AI infrastructure,...
These AI prompts can help make you a master salary negotiator at your next job interview.
The artificial-intelligence buildout is driving intense demand for networking and servers, and Hewlett Packard Enterprise is reaping the rewards.
Berkshire Hathaway is buying Alphabet's stock at a discount as part of a newly announced equity offering.
Micron stands to benefit from a favorable pricing environment, low competition - and now a new Nvidia chip, analysts say.
"I'm not looking for a 'don't do it' opinion."